Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2005
12/07/2005EP1601325A2 Antisense oligonucleotides that inhibit expression of hif-1
12/07/2005EP1266006B1 Production of recombinant muteins of blood clotting factor viii in human cell lines
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP0998568B1 Mutant having uracil phosphoribosyl transferase activity
12/07/2005EP0988059B1 Human quinone reductase 2 conjugates for adept and gdept
12/07/2005EP0922105B1 Infectious papillomavirus pseudoviral particles
12/07/2005EP0738328B1 Composition containing nucleic acids, preparation and uses
12/07/2005EP0724589B1 A method for enhancing neurone survival and agents useful for same
12/07/2005EP0716701B1 Agent comprising serine-threonine kinase for the diagnostic and therapy of tumors
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1705744A Transplantable cell
12/07/2005CN1704478A Methods for assessing patients with acute myeloid leukemia
12/07/2005CN1704123A Little interfered RNA preparation for internal preventing or curing respiratory system diseases and screening method thereof
12/07/2005CN1230540C Drosophila recombination-associated protein and methods for use
12/07/2005CN1230539C Bacterial auto-inducer inactivation protein, its coded nucleic acid molecule and uses
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230205C Gene preparations
12/07/2005CN1230204C Method of immunomodulation by means of adoptive transfer of antigernspecific cytotoxic T-cells
12/07/2005CN1230196C Erythropoiesis for treating anemia of family and raised animals
12/07/2005CN1230152C Hydrogel particle formulations
12/06/2005US6972328 can comprise DNA, RNA, PNA, or any combination or chimera thereof
12/06/2005US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972187 OAT5 molecules and uses therefor
12/06/2005US6972179 RRP sequences and knockout mice and uses thereof
12/06/2005US6972176 KVLQT1—a long QT syndrome gene
12/06/2005US6972171 mixing polynucleotides with folic acid, hormones, peptides, glycoproteins, lipids or phosphatides to form nucleotides used as drugs; genetic engineering; gene expression
12/06/2005US6972170 obtaining sample of prostate carcinoma and detecting presence of p27 protein in prostate carcinoma, the absence of p27 indicating that the prostate carcinoma is aggressive
12/06/2005US6972168 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture
12/06/2005US6972124 Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
12/01/2005WO2005114211A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor nyp5 (npy5)
12/01/2005WO2005113786A2 Diagnostics and therapeutics for diseases associated with chymase (cma1)
12/01/2005WO2005113782A1 Tc-83-derived alphavirus vectors, particles and methods
12/01/2005WO2005113780A1 Adipose-derived stem cells and lattices
12/01/2005WO2005113770A1 Anti-rhoa and -rhoc sirnas and therapeutic compositions comprising them.
12/01/2005WO2005113019A2 Methods for the treatment of autoimmune diseases
12/01/2005WO2005113018A2 Cancer treatment using viruses and camptothecins
12/01/2005WO2005113017A2 Gfap-based gene therapy for treatment of retinal diseases
12/01/2005WO2005113016A2 Modulation of glucose-6-phosphatase translocase expression
12/01/2005WO2005113015A1 Enhanced gene delivery using viral vectors
12/01/2005WO2005113014A1 siRNA TO VP-1 OF JC VIRUS AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/01/2005WO2005113013A2 Compositions of ndv and methods of use thereof for treatment of cancer
12/01/2005WO2005112961A1 The use of a replication competent virus or its recombinant in therapy
12/01/2005WO2005112887A2 Composition comprising intercalated functional-active organic compounds
12/01/2005WO2005112886A2 Methods and articles for the delivery of therapeutic agents
12/01/2005WO2005112542A2 Cartilage and bone repair composition
12/01/2005WO2005112541A2 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
12/01/2005WO2005087808A3 Growth factor binding constructs materials and methods
12/01/2005WO2005069975A3 Lysyl oxidase-like 1 (loxl1) and elastogenesis
12/01/2005WO2005065721A3 Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex
12/01/2005WO2005032595A3 Methods and compositions for the inhibition of stat5 in prostate cancer cells
12/01/2005WO2005014806A3 Conserved hbv and hcv sequences useful for gene silencing
12/01/2005WO2005013895A3 Compositions and methods for the treatment of schizophrenia and addictive disorders
12/01/2005WO2004113497A3 Gene delivery to tumors
12/01/2005WO2004094988A3 Tolerance to graft prior to thymic regeneration
12/01/2005WO2004094649A3 Tolerance to graft following thymic reactivation
12/01/2005WO2004092343A3 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005US20050267175 Anticancer agents for, lungs, leukemia and ovarian cancer or prostate glands
12/01/2005US20050267065 Modulation of Aurora B expression
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267063 Antisense modulation of p70 S6 kinase expression
12/01/2005US20050267062 Endothelial growth factors; antiischemic agents; neovascularization
12/01/2005US20050267061 Methods and compositions for treating neuropathic and neurodegenerative conditions
12/01/2005US20050267060 Combinatorial methods and compositions for treatment of melanoma
12/01/2005US20050267059 Syk-targeted nucleic acid interference
12/01/2005US20050267058 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050267022 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
12/01/2005US20050267020 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
12/01/2005US20050267009 Method of Treatment of Acute and Persistent Pain
12/01/2005US20050266568 Molecule-releasing apparatus and molecule-releasing medhod
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005US20050266565 Expression vector for use as gene delivery tool in transfer of exogenous genes into hematopoietic stem cells; improving heterologus gene expression
12/01/2005US20050266550 TC-83-derived alphavirus vectors, particles and methods
12/01/2005US20050266549 Molecular switch for regulating mammalian gene expression
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266502 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/01/2005US20050266488 Adjust efficiency translation of polypeptides; gene expression; vaccine; isolated Dna
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266484 gene therapy; a sequence which encodes the polypeptide podocin; proteinuria
12/01/2005US20050266431 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
12/01/2005US20050266422 Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides
12/01/2005US20050266406 Maxs as modifiers of the axin pathway and methods of use
12/01/2005US20050266093 Nanogene therapy for cell proliferation disorders
12/01/2005US20050266092 Loaded microspheres
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005US20050266025 Novel use
12/01/2005US20050266024 Adjuvant
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050266015 Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide
12/01/2005US20050266012 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same
12/01/2005US20050265999 Modulation of 5-HT2 receptors as a treatment for cardiovascular diseases
12/01/2005US20050265997 Cancer treatment method by inhibiting MAGE gene expression or function
12/01/2005US20050265985 nucleotide sequences that code serine/threonine protein kinase, used for analyzing or screening breast cancers; gene therapy
12/01/2005US20050265983 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
12/01/2005US20050265978 Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction
1 ... 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 ... 870